SCHEMBL3635260

SCHEMBL3635260

FC(F)(F)c1ccc(-c2cc(C(F)(F)F)nc(-c3nc(I)c[nH]3)n2)cn1

nearest known ligand 0.56

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 2/20 0.39
PTGES O14684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3633670 0.89 PTGES (0.39) PTGES
SCHEMBL3629880 0.87 PTGES (0.39) PTGES
SCHEMBL4657991 0.86 KDM4E (0.40) PTGS2
SCHEMBL4658311 0.86 KDM4E (0.52) PTGS2
SCHEMBL4657739 0.85 KDM4E (0.53)
SCHEMBL4657891 0.85 KDM4E (0.39)
SCHEMBL4657944 0.84 KDM4E (0.40)
SCHEMBL4659144 0.81 SDHB (0.36) PTGS2
SCHEMBL4659091 0.81 IDO1 (0.46)
SCHEMBL4658948 0.80 PDE4D (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3154954-A1 METABOTROPIC GLUTAMATE RECEPTOR NEGATIVE ALLOSTERIC MODULATORS (NAMS) AND USES THEREOF Sanford-Burnham Medical Research Institute (US) 2017-04-19 EP disclosed
WO-2015191630-A1 METABOTROPIC GLUTAMATE RECEPTOR NEGATIVE ALLOSTERIC MODULATORS (NAMS) AND USES THEREOF SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2015-12-17 WO disclosed
EP-2142527-A1 PYRIDINE AND PYRIMIDINE DERIVATIVES AS MGLUR2 ANTAGONISTS F. Hoffmann-Roche AG (CH) 2010-01-13 EP disclosed
WO-2008119689-A1 PYRIDINE AND PYRIMIDINE DERIVATIVES AS MGLUR2 ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2008-10-09 WO disclosed